Trent Northen, Ph.D.

Lawrence Berkeley National Laboratory
email: trnorthen@lbl.gov

Grants

Metabolite Imaging to Identify Drug Resistant Breast Cancer 2009 (Cycle 15)
IDEA (Innovative, Developmental, and Exploratory Awards) 15IB-0063 $171,892


Conserved features of cancer cells define their sensitivity to HAMLET-induced death
  Periodical: Oncogene
  Author(s): Storm, P; Aits, S; Puthia, MK; Urbano, A; Northen, T; Powers, S; Bowen, B; Chao, Y; Reind
  Yr: 2011 Vol: 30 Nbr: June 6 Pgs: 4765-4779
  Associated Grant: Metabolite Imaging to Identify Drug Resistant Breast Cancer
 
Multivariate analysis of a 3D mass spectral image for examining tissue heterogeneity.
  Periodical: Journal of Intergative Biology
  Author(s): Reindl W, Bowen BP, Balamotis MA, Green JE, Northen TR
  Yr: 2011 Vol: 3 Nbr: 4 Pgs: 460-7
  Associated Grant: Metabolite Imaging to Identify Drug Resistant Breast Cancer
 
Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis.
  Periodical: Oncogene
  Author(s): Storm P, Aits S, Puthia MK, Urbano A, Northen T, et al.
  Yr: 2011 Vol: ePub Nbr: June Pgs: 1-15
  Associated Grant: Metabolite Imaging to Identify Drug Resistant Breast Cancer
 
Dealing with the Unknown: Metabolomics and Metabolite Atlases.
  Periodical: Journal of the American Society for Mass Spectrometry
  Author(s): Bowen BP, Northen TR
  Yr: 2010 Vol: 21 Nbr: 9 Pgs: 1471-76, ePub
  Associated Grant: Metabolite Imaging to Identify Drug Resistant Breast Cancer